Onyia Jude
Related Filers (2)
Other (4)
144
Tuesday, 2/13/2024
Filing for proposed sale of securities under Rule 144
144
Wednesday, 1/31/2024
Filing for proposed sale of securities under Rule 144
144
Wednesday, 11/29/2023
Filing for proposed sale of securities under Rule 144
144
Tuesday, 8/22/2023
Filing for proposed sale of securities under Rule 144
Ownership (14)
4
Thursday, 2/15/2024
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Friday, 2/2/2024
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Friday, 12/1/2023
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/23/2023
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/7/2023
Voyager Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 2/27/2023
Voyager Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Monday, 2/27/2023
Voyager Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 2/15/2023
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/8/2023
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Thursday, 2/2/2023
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Thursday, 12/1/2022
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/2/2022
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/1/2021
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
3
Wednesday, 12/1/2021
NEUROCRINE BIOSCIENCES INC: Initial statement of beneficial ownership of securities